Fig1: Western blot analysis of Fusion glycoprotein F0 on Fusion glycoprotein F0 transfected HEK293 cell lysates using anti- Fusion glycoprotein F0 antibody at 1/500 dilution.
During virus entry, induces fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. The fusogenic activity is inactive untill entry into host cell endosome, where a furin-like protease cleaves off a small peptide between F1 and F2. Interacts directly with heparan sulfate and may participate in virus attachment. Furthermore, the F2 subunit was identifed as the major determinant of RSV host cell specificity. Later in infection, proteins F expressed at the plasma membrane of infected cells can mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis. The fusion protein is also able to trigger p53-dependent apoptosis.
Immunogen
Synthetic peptide within newcastle disease virus Fusion glycoprotein F0 aa 504-553 / 553.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
ICC/IFWB
WB:1:500-1,000 ELISA:1:5,000-1:10,000
Species Reactivity
Avian
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
Fusion glycoprotein F0 antibody
Fusion glycoprotein F1 antibody
Fusion glycoprotein F2 antibody
Fusion protein (F) antibody
RSV fusion protein antibody
Fig1: Western blot analysis of Fusion glycoprotein F0 on Fusion glycoprotein F0 transfected HEK293 cell lysates using anti- Fusion glycoprotein F0 antibody at 1/500 dilution.
Positive Control
Fusion glycoprotein F0 transfected HEK293 cell.
Application Notes
WB:1:500-1,000 ELISA:1:5,000-1:10,000
Additional Information
Form
Liquid
Storage Instructions
Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.